Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-04-27

FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved ANI Pharmaceuticals' supplemental application for ATACAND (candesartan cilexetil). This action updates the drug's labeling as part of the supplemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacand (candesartan)

Snippet

SUPPL AP for ATACAND (CANDESARTAN CILEXETIL)